WELLCELL H-NEW Announces Appointment of Hu Hongyu as Independent Non-Executive Director

Stock News06-26

WELLCELL H-NEW (ASX: 02477) has announced board changes effective June 26, 2026. Mr. Lam Kai Ho has tendered his resignation as a non-executive director due to his decision to dedicate more time to his other business arrangements.

Similarly, Mr. Wong Chi Man has resigned from his position as an independent non-executive director for the same reason. Concurrently with his resignation, he has stepped down from his roles as the Chairman of the Board Audit Committee, the Remuneration Committee, and the Nomination Committee, as well as his membership on the Board Investment Committee.

Ms. Hu Hongyu has been appointed as an independent non-executive director, Chairman of the Remuneration Committee, and a member of both the Audit Committee and the Nomination Committee, with her appointments also taking effect on June 26, 2026.

Mr. Qian Fenglei, the Chairman of the Board and an executive director, has been appointed as the Chairman of the Nomination Committee and a member of the Investment Committee. Independent non-executive director Mr. Chen Weiduan has been appointed as the Chairman of the Audit Committee.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment